Molecular therapy for acute respiratory distress syndrome: GATA-binding factor 6 inhibits acute lung injury via down regulation of its target gene, 15/April/2015, 22.04

Small molecule-based Life-span extension therapy: Phosphorylated glucosamine inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span via up regulation of its target gene, 15/April/2015, 22.58
April 15, 2015
Small molecule-based Life-span extension therapy: Citrus ichangensis peel extract (CIE) inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span via up regulation of its target gene, 16/April/2015, 8.15 am
April 16, 2015
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, Molecular therapy for acute respiratory distress syndrome: GATA-binding factor 6 inhibits acute lung injury via down regulation of its target gene, 15/April/2015, 22.04, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Significance: This study suggests, for the first time, that GATA-binding factor 6, by suppressing the expression of its target gene, it may inhibit acute lung injury. Thereby, it may inhibit the progression of acute respiratory distress syndrome.  Thus, pharmacological formulations encompassing “GATA-binding factor 6 activators  may be used to inhibit the progression of acute respiratory distress syndrome.

Amount: $ 300

Undisclosed information: How american ginseng inhibits the progression of acute respiratory distress syndrome

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Comments are closed.